BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 19015012)

  • 1. Alkaloids: future prospective to combat leishmaniasis.
    Mishra BB; Kale RR; Singh RK; Tiwari VK
    Fitoterapia; 2009 Mar; 80(2):81-90. PubMed ID: 19015012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fighting against Leishmaniasis: search of alkaloids as future true potential anti-Leishmanial agents.
    Mishra BB; Singh RK; Srivastava A; Tripathi VJ; Tiwari VK
    Mini Rev Med Chem; 2009 Jan; 9(1):107-23. PubMed ID: 19149664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural product based leads to fight against leishmaniasis.
    Singh N; Mishra BB; Bajpai S; Singh RK; Tiwari VK
    Bioorg Med Chem; 2014 Jan; 22(1):18-45. PubMed ID: 24355247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Manzamine alkaloids as antileishmanial agents: A review.
    Ashok P; Lathiya H; Murugesan S
    Eur J Med Chem; 2015 Jun; 97():928-36. PubMed ID: 25023608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alkaloids as potential anti-tubercular agents.
    Kishore N; Mishra BB; Tripathi V; Tiwari VK
    Fitoterapia; 2009 Apr; 80(3):149-63. PubMed ID: 19344681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leishmanicidal effects of piperine, its derivatives, and analogues on Leishmania amazonensis.
    Ferreira C; Soares DC; Barreto-Junior CB; Nascimento MT; Freire-de-Lima L; Delorenzi JC; Lima ME; Atella GC; Folly E; Carvalho TM; Saraiva EM; Pinto-da-Silva LH
    Phytochemistry; 2011 Dec; 72(17):2155-64. PubMed ID: 21885074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular mechanisms of antimony resistance in Leishmania.
    Ashutosh ; Sundar S; Goyal N
    J Med Microbiol; 2007 Feb; 56(Pt 2):143-53. PubMed ID: 17244793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Limitations of Current Therapeutic Options, Possible Drug Targets and Scope of Natural Products in Control of Leishmaniasis.
    Tiwari N; Gedda MR; Tiwari VK; Singh SP; Singh RK
    Mini Rev Med Chem; 2018; 18(1):26-41. PubMed ID: 28443518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent advances in antileishmanial drug development.
    Davis AJ; Kedzierski L
    Curr Opin Investig Drugs; 2005 Feb; 6(2):163-9. PubMed ID: 15751739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rational approaches for drug designing against leishmaniasis.
    Shukla AK; Singh BK; Patra S; Dubey VK
    Appl Biochem Biotechnol; 2010 Apr; 160(8):2208-18. PubMed ID: 19756413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Highly effective oral amphotericin B formulation against murine visceral leishmaniasis.
    Wasan KM; Wasan EK; Gershkovich P; Zhu X; Tidwell RR; Werbovetz KA; Clement JG; Thornton SJ
    J Infect Dis; 2009 Aug; 200(3):357-60. PubMed ID: 19545212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An antileishmanial prenyloxy-naphthoquinone from roots of Plumbago zeylanica.
    Mishra BB; Gour JK; Kishore N; Singh RK; Tripathi V; Tiwari VK
    Nat Prod Res; 2013 Mar; 27(4-5):480-5. PubMed ID: 22708724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leishmaniasis: drugs in the clinic, resistance and new developments.
    Ouellette M; Drummelsmith J; Papadopoulou B
    Drug Resist Updat; 2004; 7(4-5):257-66. PubMed ID: 15533763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Miltefosine: issues to be addressed in the future.
    Berman J; Bryceson AD; Croft S; Engel J; Gutteridge W; Karbwang J; Sindermann H; Soto J; Sundar S; Urbina JA
    Trans R Soc Trop Med Hyg; 2006 Dec; 100 Suppl 1():S41-4. PubMed ID: 16750231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leishmaniasis: current status of available drugs and new potential drug targets.
    Singh N; Kumar M; Singh RK
    Asian Pac J Trop Med; 2012 Jun; 5(6):485-97. PubMed ID: 22575984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimicrobial peptides for leishmaniasis.
    Cobb SL; Denny PW
    Curr Opin Investig Drugs; 2010 Aug; 11(8):868-75. PubMed ID: 20721829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent advances in leishmaniasis treatment.
    Tiuman TS; Santos AO; Ueda-Nakamura T; Filho BP; Nakamura CV
    Int J Infect Dis; 2011 Aug; 15(8):e525-32. PubMed ID: 21605997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current approaches to discover marine antileishmanial natural products.
    Tempone AG; Martins de Oliveira C; Berlinck RG
    Planta Med; 2011 Apr; 77(6):572-85. PubMed ID: 21243582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Visceral leishmaniasis in Africa.
    Davidson R; Croft S
    Afr Health; 1992 Jul; 14(5):18-9. PubMed ID: 12317771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leishmanicidal activity of benzophenones and extracts from Garcinia brasiliensis Mart. fruits.
    Pereira IO; Marques MJ; Pavan AL; Codonho BS; BarbiƩri CL; Beijo LA; Doriguetto AC; D'Martin EC; dos Santos MH
    Phytomedicine; 2010 Apr; 17(5):339-45. PubMed ID: 19762221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.